>
JPMorgan CEO Dimon says US economy is booming
Divide and Conquer: The Government's Propaganda of Fear and Fake News
This Political Ad Is So Ridiculous You'll Think It's Satire
"He Knows too Much" - Suge Knight on Diddy's Knowledge of Music's Darkest Secrets
Blazing bits transmitted 4.5 million times faster than broadband
Scientists Close To Controlling All Genetic Material On Earth
Doodle to reality: World's 1st nuclear fusion-powered electric propulsion drive
Phase-change concrete melts snow and ice without salt or shovels
You Won't Want To Miss THIS During The Total Solar Eclipse (3D Eclipse Timeline And Viewing Tips
China Room Temperature Superconductor Researcher Had Experiments to Refute Critics
5 video games we wanna smell, now that it's kinda possible with GameScent
Unpowered cargo gliders on tow ropes promise 65% cheaper air freight
Wyoming A Finalist For Factory To Build Portable Micro-Nuclear Plants
(Natural News) Cannabinoids may show potential in the treatment of various skin diseases, according to a recent analysis. Health experts at the University of Colorado Anschutz Medical Campus examined current literature on the effects of cannabinoids on skin diseases and confirmed that pharmaceutical products containing the compound may prove effective in treating eczema, psoriasis, and both atopic and contact dermatitis.
According to senior author Dr. Robert Dellavalle, Associate Professor of Dermatology at the University of Colorado School of Medicine, the compound's most promising effect is addressing severe itch. The senior author cited one study where eight out of 21 patients who used a cannabinoid cream twice daily for three weeks were able to completely cure severe itching or pruritus. According to the study, cannabinoids helped relieve dry skin, which triggers itch in patients.
The research team also found that tetrahydrocannabinol, the active ingredient in marijuana, helped reduce swelling and inflammation in mice. The experts also noted that animal models of melanoma exhibited a significant inhibition of tumor growth following tetrahydrocannabinol injection. According to Dellavalle, the cannabinoid's anti-inflammatory properties may play a role in the beneficial effects of therapies using the compound. Dellavalle said the treatments used were cannabinoid drugs that spurred little to no psychotropic effects, indicating that they can be used in skin disorders. He also stressed that cannabinoids may be an effective alternative for patients who were non-responsive to other itch and skin disease therapies.